| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |